Nkarta, Inc. - stock earnings
NKTX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -25.6 million USD | ? USD |
2023Q2 | -33.3 million USD | ? USD |
2023Q1 | -27.3 million USD | ? USD |
2022Q4 | -35.5 million USD | ? USD |
2022Q3 | -26.4 million USD | ? USD |
2022Q2 | -27.6 million USD | ? USD |
2022Q1 | -26.1 million USD | ? USD |
2021Q4 | -22.8 million USD | ? USD |
2021Q3 | -22.4 million USD | ? USD |
2021Q2 | -21.5 million USD | ? USD |
2021Q1 | -19.4 million USD | ? USD |
2020Q4 | -17.9 million USD | ? USD |
2020Q3 | -13.7 million USD | ? USD |
2020Q2 | -51.1 million USD | ? USD |
2020Q1 | -8.7 million USD | ? USD |
2019Q4 | -10.5 million USD | 385 USD |
2019Q3 | -2.7 million USD | ? USD |
2019Q2 | -4.8 million USD | 2308 USD |
2019Q1 | -3.1 million USD | 113077 USD |
NKTX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -117.5 million USD | ? USD |
2022 | -119.4 million USD | ? USD |
2021 | -83.9 million USD | ? USD |
2020 | -50.4 million USD | 385 USD |
2019 | -22.9 million USD | 115385 USD |
2018 | -274503 USD | 6.6 million USD |
NKTX
Price: $7.10
52 week price:
Earnings Per Share: -2.40 USD
P/E Ratio: -4.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 296100
Market Capitalization: 615.5 million